SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Professional Translational Research: A New Hybrid Paradigm in Early Drug Discovery
9 references·1 citing·32 second hop
Professional Translational Research: A New Hybrid Paradigm in Early Drug Discovery (2015)Professional Translational Research: A Ne…Mitigating risk in academic preclinical drug discovery (2015)Mitigating risk in academic p…Medicinal Chemists of the 21st Century—Who Are We and Where to Go? (2015)Medicinal Chemists of the 21s…Academic drug discovery centres: the economic and organisational sustainability of an emerging model (2014)Academic drug discovery centr…Opening the lead generation toolbox (2013)Opening the lead generation t…Translational research: the changing landscape of drug discovery (2012)Translational research: the c…The productivity crisis in pharmaceutical R&D (2011)The productivity crisis in ph…Drug buddies (2011)Drug buddiesBelieve it or not: how much can we rely on published data on potential drug targets? (2011)Believe it or not: how much c…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…The Evolving Role of the Medicinal Chemist (2016)The Evolving Role of the Medi…Drug Discovery: A Modern Decathlon (2013)Priorities in Scientific Discovery: A Chapter in the Sociology of Science (1957)Toward a new economics of science (1994)Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups (2003)Open for collaboration: an academic platform for drug discovery and development at SciLifeLab (2016)How Much Longer Will We Put Up With $100,000 Cancer Drugs? (2017)The endless frontier? The recent increase of R&D productivity in pharmaceuticals (2020)Investigating the factors that diminish the barriers to university–industry collaboration (2010)Opportunities and Challenges for Drug Development: Public–Private Partnerships, Adaptive Designs and Big Data (2016)Pharmaceutical Industry, Academia, Regulatory Authorities and End User Collaboration in Successful Drug Discovery and Development (2021)Lessons from 60 years of pharmaceutical innovation (2009)The Drug Discovery and Development Industry in India—Two Decades of Proprietary Small‐Molecule R&D (2017)When fragments link: a bibliometric perspective on the development of fragment-based drug discovery (2018)A bibliometric measure of translational science (2020)Why Most Published Research Findings Are False (2005)What errors do peer reviewers detect, and does training improve their ability to detect them? (2008)Power failure: why small sample size undermines the reliability of neuroscience (2013)Estimating the reproducibility of psychological science (2015)Why Most Published Research Findings Are False (2019)Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal (2024)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)The price of innovation: new estimates of drug development costs (2003)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework (2014)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Can the pharmaceutical industry reduce attrition rates? (2004)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)US academic drug discovery (2011)Bringing together the academic drug discovery community (2013)2014 FDA drug approvals (2015)
this work references cited by second hop

References

  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,686 cited
  • 2011Believe it or not: how much can we rely on published data on potential drug targets?1,885 cited
  • 2011The productivity crisis in pharmaceutical R&D918 cited
  • 2015Mitigating risk in academic preclinical drug discovery192 cited
  • 2012Translational research: the changing landscape of drug discovery46 cited
  • 2014Academic drug discovery centres: the economic and organisational sustainability of an emerging model25 cited
  • 2013Opening the lead generation toolbox17 cited
  • 2011Drug buddies13 cited
  • 2015Medicinal Chemists of the 21st Century—Who Are We and Where to Go?9 cited

Cited by

  • 2016The Evolving Role of the Medicinal Chemist4 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work